These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29226890)

  • 41. [The predictive value of epicardial adipose tissue and inflammatory factors for in-stent restenosis].
    Zhou QN; Lin WH; Jing R; Liu JJ; Shi HY; Yang RF; Gao P; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(47):3732-3736. PubMed ID: 31874499
    [No Abstract]   [Full Text] [Related]  

  • 42. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
    Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship of TIMI risk index with SYNTAX and Gensini risk scores in predicting the extent and severity of coronary artery disease in patients with STEMI undergoing primary percutaneous coronary intervention.
    Acet H; Ertaş F; Bilik MZ; Aydın M; Yüksel M; Polat N; Yıldız A; Özyurtlu F; Akıl MA; Çiftçi L; Özbek M; Alan S; Toprak N
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):257-66. PubMed ID: 25784498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes of plasma Rap1A levels in patients with in-stent restenosis after percutaneous coronary intervention and the underlying mechanisms.
    Gao H; Kuang Y; Liu Y; Zhang Y; Wang P; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1650-1658. PubMed ID: 38432855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
    Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
    J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease.
    Chen BW; Liu JJ; Xing JH; Liu HD; Wei YZ; Xue XF; Gu HP; Tao HL
    Clin Appl Thromb Hemost; 2022; 28():10760296221079334. PubMed ID: 35187964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors associated with intra-stent restenosis after percutaneous coronary intervention.
    Alexandrescu DM; Mitu O; Costache II; Macovei L; Mitu I; Alexandrescu A; Georgescu CA
    Exp Ther Med; 2021 Oct; 22(4):1141. PubMed ID: 34504587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.
    Liu J; Liu Y; Jia K; Huo Z; Huo Q; Liu Z; Li Y; Han X; Wang R
    Medicine (Baltimore); 2018 Apr; 97(17):e0366. PubMed ID: 29702981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Role of the SYNTAX score in assessing the outcomes of percutaneous interventions in patients with ST segment elevation myocardial infarction].
    Tarasov RS; Ganyukov VI; Barbarash OL; Barbarash LS
    Angiol Sosud Khir; 2016; 22(1):38-45. PubMed ID: 27100536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era.
    Lee MS; Pessegueiro A; Zimmer R; Jurewitz D; Tobis J
    J Invasive Cardiol; 2008 Aug; 20(8):401-3. PubMed ID: 18688064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the Korean DES ISR multicenter registry study [KISS]).
    Ko YG; Kim JS; Kim BK; Choi D; Hong MK; Jeon DW; Yang JY; Ahn YK; Jeong MH; Yu CW; Yun KH; Lim DS; Jang Y;
    Am J Cardiol; 2012 Mar; 109(5):607-13. PubMed ID: 22172241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between Gensini score and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zencirci AE; Zencirci E; Degirmencioglu A; Karakus G; Ugurlucan M; Gunduz S; Ozden K; Erdem A; Karadeniz F; Ekmekci A; Erer H; Sayar N; Eren M
    Kardiol Pol; 2014; 72(6):494-503. PubMed ID: 24408069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids.
    Qian H; Luo Z; Xiao C; Chen J; Li D; Xu H; He P; Zhou X; Zhang T; Min X
    Postgrad Med J; 2018 Sep; 94(1115):489-494. PubMed ID: 30301834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus.
    Sukhija R; Aronow WS; Sureddi R; Aleti S; Molavi B; Sachdeva R; Mehta JL
    Am J Cardiol; 2007 Sep; 100(5):777-80. PubMed ID: 17719319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study.
    Zhang J; Zhang Q; Zhao K; Bian YJ; Liu Y; Xue YT
    Medicine (Baltimore); 2022 Nov; 101(47):e31707. PubMed ID: 36451388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
    Zhao L; Zhu W; Zhang X; He D; Guo C
    BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
    Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
    Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.